Dr. Neil C. Sheppard

Head of the Therapeutic Innovation in NK cell (THINK) Lab & Adj. Assoc. Prof. of Path & Lab Medicine, University of Pennsylvania, Ex-GSK

Dr. Neil Sheppard leads a lab focused on novel and enhanced CAR-T and NK therapies for cancer at the University of Pennsylvania’s Center for Cellular Immunotherapies (CCI), where he also oversees the combination strategy for a clinical stage CAR-T as part of Prof Carl June’s team.
Educated in the UK at the Universities of Bristol and Oxford, Neil has 20 years’ experience with immunotherapies and vaccines, advancing multiple CAR-T and TCR-T programs through successful INDs into PhI FTIH, or PhI/II Immuno-Oncology combination studies. His experience includes over 12 years in Big Pharma (GSK and Pfizer) & Biotech (Tmunity).